VivoSeq
Other

Hemostasis

0

Pipeline Programs

5

Active Trials

1

Companies Involved

Hemostasis is an early-stage landscape with 0 programs across 1 company. The most active players are Bayer.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

13

clinical trials

Completed7 · 54%
Recruiting4 · 31%
Unknown status1 · 8%
Not yet recruiting1 · 8%

Trial Activity

13 trials

sTErnAl heMostasiS Trial
Recruiting·WWakeMed Health and Hospitals·Phase 4·NCT06511778·60 enrolled
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
Completed·EEstetra·Phase 1/2·NCT02957630·101 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)